APA (7th ed.) Citation

K, Y., T, A., K, N., Y, K., T, M., A, I., . . . E, H. (2025). Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Retrospective Cohort Study. Annals of surgical oncology, 32(5), 3603. https://doi.org/10.1245/s10434-025-16956-z

Chicago Style (17th ed.) Citation

K, Yamane, et al. "Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Retrospective Cohort Study." Annals of Surgical Oncology 32, no. 5 (2025): 3603. https://doi.org/10.1245/s10434-025-16956-z.

MLA (9th ed.) Citation

K, Yamane, et al. "Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Retrospective Cohort Study." Annals of Surgical Oncology, vol. 32, no. 5, 2025, p. 3603, https://doi.org/10.1245/s10434-025-16956-z.